Ascendis Pharma A (ASND) Change in Inventory (2021 - 2026)

Ascendis Pharma A (ASND) has 6 years of Change in Inventory data on file, last reported at -$15.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 661.89% year-over-year to -$15.0 million; the trailing twelve-month figure through Mar 2026 stood at -$24.5 million (up 62.38% YoY), and the FY2025 full-year result was -$6.9 million, up 92.65% from the prior year.
• Change in Inventory eased to -$15.0 million in Q1 2026, from $583185.8 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $2.7 million in Q1 2025 to a low of -$32.2 million in Q4 2024.
• A 5-year average of -$15.2 million and a median of -$18.6 million in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory sank 762.95% in 2023 and jumped 110.35% in 2025, its largest moves.
• Tracing ASND's Change in Inventory over 5 years: stood at -$27.2 million in 2022, then rose by 21.79% to -$21.3 million in 2023, then tumbled by 51.37% to -$32.2 million in 2024, then soared by 101.81% to $583185.8 in 2025, then plunged by 2672.21% to -$15.0 million in 2026.
• Business Quant data shows ASND's Change in Inventory at -$15.0 million in Q1 2026, $583185.8 in Q4 2025, and $1.6 million in Q3 2025.